Clinical studies recruiting near Paramus

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · The Valley Hospital - Luckow Pavilion · National Cancer Institute (NCI) · NCT05564390 The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
Phase 2 · Valley - Mount Sinai Comprehensive Cancer Care · Icahn School of Medicine at Mount Sinai · NCT05419089 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · The Valley Hospital - Luckow Pavilion · PrECOG, LLC. · NCT06538038 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · The Valley Hospital - Luckow Pavilion · NRG Oncology · NCT05946213 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · The Valley Hospital - Luckow Pavilion · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · The Valley Hospital - Luckow Pavilion · Alliance for Clinical Trials in Oncology · NCT06632327 Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I
Phase 3 · Alkermes Investigator Site · Alkermes, Inc. · NCT05303064 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · Valley Health Systems - Ridgewood Campus ( Site 0125) · Merck Sharp & Dohme LLC · NCT06890884 Prevail Global Study
NA · The Valley Hospital · Medtronic Vascular · NCT06535854 Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA
Phase N/A · The Valley Hospital · CathVision ApS · NCT07275151 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · The Valley Hospital - Luckow Pavilion · NRG Oncology · NCT06748222 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · Hackensack University Medical Center;Department of Neurology · Hoffmann-La Roche · NCT07174310 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · The Valley Hospital, Inc. · Eli Lilly and Company · NCT06119581 Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin
Phase 2 · The Valley Hospital - Luckow Pavilion · National Cancer Institute (NCI) · NCT05554393 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · The Valley Hospital - Luckow Pavilion · National Cancer Institute (NCI) · NCT07198074 Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer
Phase 1/Phase 2 · John Theurer Cancer Center at From Road · Pfizer · NCT07227298 Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Trea
Phase 2 · The Valley Hospital - Luckow Pavilion · National Cancer Institute (NCI) · NCT06317649 REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Phase N/A · The Valley Hospital · Medtronic Cardiovascular · NCT06777368 Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for L
Phase 2/Phase 3 · The Valley Hospital - Valley Health System - The Robert and · BioNTech SE · NCT06712316 A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melan
Phase 3 · The Valley Hospital Inc. · Regeneron Pharmaceuticals · NCT06246916 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · The Valley Hospital - Luckow Pavilion · National Cancer Institute (NCI) · NCT04267848 Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years
Phase 3 · Research Site · AstraZeneca · NCT06307665 Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Phase 1/Phase 2 · The Valley Hospital - Luckow Pavilion · Genprex, Inc. · NCT04486833 Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Phase 3 · The Valley Hospital - Luckow Pavilion · National Cancer Institute (NCI) · NCT04181060 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After
Phase 3 · The Valley Hospital - Luckow Pavilion · Alliance for Clinical Trials in Oncology · NCT05812807 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · North East Regional Surgical Center · Stryker Instruments · NCT03072927 A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib
Phase 3 · The Valley Hospital, Inc · BeOne Medicines · NCT06742996 A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 · The Valley Hospital Paramus · Novo Nordisk A/S · NCT07567001 A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lun
Phase 2 · Valley Health Systems - Ridgewood Campus ( Site 0010) · Merck Sharp & Dohme LLC · NCT07221474

Look up another city

Look up another condition